141 related articles for article (PubMed ID: 17131325)
1. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.
Chung YL; Troy H; Judson IR; Leek R; Leach MO; Stubbs M; Harris AL; Griffiths JR
Clin Cancer Res; 2004 Jun; 10(11):3863-70. PubMed ID: 15173095
[TBL] [Abstract][Full Text] [Related]
3. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
[TBL] [Abstract][Full Text] [Related]
4. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy.
Li CW; Negendank WG; Padavic-Shaller KA; O'Dwyer PJ; Murphy-Boesch J; Brown TR
Clin Cancer Res; 1996 Feb; 2(2):339-45. PubMed ID: 9816177
[TBL] [Abstract][Full Text] [Related]
6. Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.
Besnard T; Renée N; Etienne-Grimaldi MC; François E; Milano G
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):117-20. PubMed ID: 18562256
[TBL] [Abstract][Full Text] [Related]
7. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver.
Klomp DW; Van Laarhoven HW; Kentgens AP; Heerschap A
Magn Reson Med; 2003 Aug; 50(2):303-8. PubMed ID: 12876706
[TBL] [Abstract][Full Text] [Related]
8. (19)F MRSI of capecitabine in the liver at 7 T using broadband transmit-receive antennas and dual-band RF pulses.
van Gorp JS; Seevinck PR; Andreychenko A; Raaijmakers AJ; Luijten PR; Viergever MA; Koopman M; Boer VO; Klomp DW
NMR Biomed; 2015 Nov; 28(11):1433-42. PubMed ID: 26373355
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
[TBL] [Abstract][Full Text] [Related]
10. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
Malet-Martino M; Gilard V; Desmoulin F; Martino R
Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs.
Martino R; Gilard V; Desmoulin F; Malet-Martino M
J Pharm Biomed Anal; 2005 Aug; 38(5):871-91. PubMed ID: 16087049
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous 3D NMR spectroscopy of proton-decoupled fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Gonen O; Murphy-Boesch J; Li CW; Padavic-Shaller K; Negendank WG; Brown TR
Magn Reson Med; 1997 Feb; 37(2):164-9. PubMed ID: 9001138
[TBL] [Abstract][Full Text] [Related]
13. Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs.
Martino R; Malet-Martino M; Gilard V
Curr Drug Metab; 2000 Nov; 1(3):271-303. PubMed ID: 11465049
[TBL] [Abstract][Full Text] [Related]
14. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.
van Laarhoven HW; Punt CJ; Kamm YJ; Heerschap A
Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
16. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
17. Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.
Twelves C; Glynne-Jones R; Cassidy J; Schüller J; Goggin T; Roos B; Banken L; Utoh M; Weidekamm E; Reigner B
Clin Cancer Res; 1999 Jul; 5(7):1696-702. PubMed ID: 10430071
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study for clinical pharmacokinetics of oral fluorine anticancer medicines using the commercial MRI system 19F-MRS.
Ikehira H; Girard F; Obata T; Ito H; Yoshitomi H; Miyazaki M; Nakajima N; Kamei H; Kanazawa Y; Takano H; Ito H; Tanada S; Sasaki Y
Br J Radiol; 1999 Jun; 72(858):584-9. PubMed ID: 10560341
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous 3D NMR spectroscopy of fluorine and phosphorus in human liver during 5-fluorouracil chemotherapy.
Li CW; Gonen O
Magn Reson Med; 1996 Jun; 35(6):841-7. PubMed ID: 8744011
[TBL] [Abstract][Full Text] [Related]
20. A glucuronidation pathway of capecitabine occurs in rats but not in mice and humans.
Desmoulin F; Claparols C; Bon D; Larrieu G; Martino R; Malet-Martino M
Drug Metab Lett; 2007 Apr; 1(2):101-7. PubMed ID: 19356028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
